FDA Rejects MDMA-AT for PTSD, but Lykos Vows to Push on

Despite the FDA's rejection of MDMA-assisted therapy, Lykos Therapeutics plans to push ahead for approval, despite internal turmoil and layoffs of 75% of company staff.
Medscape Medical News

source https://www.medscape.com/viewarticle/fda-rejects-mdma-ptsd-lykos-others-vow-push-2024a1000fvl?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?